{"id":952142,"date":"2026-04-16T11:55:51","date_gmt":"2026-04-16T15:55:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/"},"modified":"2026-04-16T11:55:51","modified_gmt":"2026-04-16T15:55:51","slug":"immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/","title":{"rendered":"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky"},"content":{"rendered":"

\nImmutep Reported TACTI-004 Futility Analysis Was “On Track” in January 2026 — Weeks Later the Trial Was Halted After Failing to Meet Efficacy Endpoints
\n<\/h2>\n
\n

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) — Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the futility analysis for its Phase III TACTI-004 trial was “on track for the first quarter of CY2026.” On March 13, 2026, the Independent Data Monitoring Committee recommended halting the trial entirely after the interim futility analysis showed the drug was unlikely to meet its efficacy endpoints — and the stock collapsed approximately 80-90%. Those who suffered a loss on IMMP are encouraged to\u00a0submit their information here<\/a>. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com<\/a> or by telephone at (212) 363-7500.<\/p>\n

The timeline raises a stark contrast between what investors were told and what followed. In its January 30, 2026 6-K filing, Immutep described “strong operational progress” for the TACTI-004 (KEYNOTE-F91) Phase III trial of eftilagimod alfa in first-line non-small-cell lung cancer. The Company characterized the futility analysis as proceeding on schedule. Just six weeks later, the IDMC disclosed that the analysis had determined the trial was unlikely to meet its primary efficacy endpoints and recommended halting enrollment.<\/p>\n

Immutep did not disclose any negative changes in the trial\u2019s outlook between the January 30 filing and the March 13 announcement. The stock lost approximately 80-90% of its value in a single session following the IDMC recommendation.<\/p>\n

Shareholders who purchased IMMP and suffered a loss are encouraged to click here to discuss their legal rights<\/a>. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com<\/a> or by telephone at (212) 363-7500.<\/p>\n

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services’ Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.<\/p>\n

CONTACT:<\/p>\n

Levi & Korsinsky, LLP<\/p>\n

Joseph E. Levi, Esq.<\/p>\n

Ed Korsinsky, Esq.<\/p>\n

33 Whitehall Street, 27th Floor<\/p>\n

New York, NY 10004<\/p>\n

\n jlevi@levikorsinsky.com<\/a>\n <\/p>\n

Tel: (212) 363-7500<\/p>\n

Fax: (212) 363-7171<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Immutep Reported TACTI-004 Futility Analysis Was “On Track” in January 2026 — Weeks Later the Trial Was Halted After Failing to Meet Efficacy Endpoints NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) — Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the futility analysis for its Phase III TACTI-004 trial was “on track for the first quarter of CY2026.” On March 13, 2026, the Independent Data Monitoring Committee recommended halting the trial entirely after the interim futility analysis showed the drug was unlikely to meet its efficacy endpoints — and the stock collapsed approximately 80-90%. Those who suffered a loss on IMMP are … <\/p>\n

Continue reading “IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-952142","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Immutep Reported TACTI-004 Futility Analysis Was “On Track” in January 2026 — Weeks Later the Trial Was Halted After Failing to Meet Efficacy Endpoints NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) — Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the futility analysis for its Phase III TACTI-004 trial was “on track for the first quarter of CY2026.” On March 13, 2026, the Independent Data Monitoring Committee recommended halting the trial entirely after the interim futility analysis showed the drug was unlikely to meet its efficacy endpoints — and the stock collapsed approximately 80-90%. Those who suffered a loss on IMMP are … Continue reading "IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-16T15:55:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky\",\"datePublished\":\"2026-04-16T15:55:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/\"},\"wordCount\":388,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/\",\"name\":\"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=\",\"datePublished\":\"2026-04-16T15:55:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/","og_locale":"en_US","og_type":"article","og_title":"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Market Newsdesk","og_description":"Immutep Reported TACTI-004 Futility Analysis Was “On Track” in January 2026 — Weeks Later the Trial Was Halted After Failing to Meet Efficacy Endpoints NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) — Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the futility analysis for its Phase III TACTI-004 trial was “on track for the first quarter of CY2026.” On March 13, 2026, the Independent Data Monitoring Committee recommended halting the trial entirely after the interim futility analysis showed the drug was unlikely to meet its efficacy endpoints — and the stock collapsed approximately 80-90%. Those who suffered a loss on IMMP are … Continue reading \"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-16T15:55:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky","datePublished":"2026-04-16T15:55:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/"},"wordCount":388,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/","name":"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=","datePublished":"2026-04-16T15:55:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MDg2MSM3NTM4Mzc1IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immp-investor-alert-immutep-ltd-securities-fraud-investigation-investors-with-losses-may-seek-to-lead-the-class-action-after-management-allegedly-misrepresented-trial-progress-levi-korsinsk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation – Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/952142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=952142"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/952142\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=952142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=952142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=952142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}